Novartis, Apotex Resolve Suit Over Myfortic Patents
Apotex Inc. on Thursday resolved a suit brought in New Jersey federal court by Novartis AG accusing the generics manufacturer of infringing its patents related to the immunosuppressive drug Myfortic....To view the full article, register now.
Already a subscriber? Click here to view full article